Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 239

1.

Synthetic Semiflexible and Bioactive Brushes.

Voerman D, Schluck M, Weiden J, Joosten B, Eggermont LJ, van den Eijnde T, Ignacio B, Cambi A, Figdor CG, Kouwer PHJ, Verdoes M, Hammink R, Rowan AE.

Biomacromolecules. 2019 Jul 8;20(7):2587-2597. doi: 10.1021/acs.biomac.9b00385. Epub 2019 Jun 13.

2.

Biomaterial-Based Activation and Expansion of Tumor-Specific T Cells.

Schluck M, Hammink R, Figdor CG, Verdoes M, Weiden J.

Front Immunol. 2019 May 3;10:931. doi: 10.3389/fimmu.2019.00931. eCollection 2019.

3.

ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation.

Cruz LJ, Tacken PJ, van der Schoot JMS, Rueda F, Torensma R, Figdor CG.

Molecules. 2019 May 12;24(9). pii: E1825. doi: 10.3390/molecules24091825.

4.

Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity.

Fennemann FL, de Vries IJM, Figdor CG, Verdoes M.

Front Immunol. 2019 Apr 16;10:824. doi: 10.3389/fimmu.2019.00824. eCollection 2019.

5.

Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery.

Weiden J, Voerman D, Dölen Y, Das RK, van Duffelen A, Hammink R, Eggermont LJ, Rowan AE, Tel J, Figdor CG.

Front Immunol. 2018 Nov 28;9:2798. doi: 10.3389/fimmu.2018.02798. eCollection 2018.

6.

Biophysical Characterization of CD6-TCR/CD3 Interplay in T Cells.

Meddens MBM, Mennens SFB, Celikkol FB, Te Riet J, Kanger JS, Joosten B, Witsenburg JJ, Brock R, Figdor CG, Cambi A.

Front Immunol. 2018 Oct 9;9:2333. doi: 10.3389/fimmu.2018.02333. eCollection 2018.

7.

C-type lectin-like receptor 2 (CLEC-2)-dependent dendritic cell migration is controlled by tetraspanin CD37.

de Winde CM, Matthews AL, van Deventer S, van der Schaaf A, Tomlinson ND, Jansen E, Eble JA, Nieswandt B, McGettrick HM, Figdor CG, Tomlinson MG, Acton SE, van Spriel AB.

J Cell Sci. 2018 Oct 2;131(19). pii: jcs214551. doi: 10.1242/jcs.214551.

8.

A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles.

Operti MC, Fecher D, van Dinther EAW, Grimm S, Jaber R, Figdor CG, Tagit O.

Int J Pharm. 2018 Oct 25;550(1-2):140-148. doi: 10.1016/j.ijpharm.2018.08.044. Epub 2018 Aug 23.

PMID:
30144511
9.

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells.

Wimmers F, Subedi N, van Buuringen N, Heister D, Vivié J, Beeren-Reinieren I, Woestenenk R, Dolstra H, Piruska A, Jacobs JFM, van Oudenaarden A, Figdor CG, Huck WTS, de Vries IJM, Tel J.

Nat Commun. 2018 Aug 20;9(1):3317. doi: 10.1038/s41467-018-05784-3.

10.

Dendritic cells in cancer immunotherapy.

Le Gall CM, Weiden J, Eggermont LJ, Figdor CG.

Nat Mater. 2018 Jun;17(6):474-475. doi: 10.1038/s41563-018-0093-6. No abstract available.

PMID:
29795222
11.

Endolysosomal-Escape Nanovaccines through Adjuvant-Induced Tumor Antigen Assembly for Enhanced Effector CD8+ T Cell Activation.

Qiu L, Valente M, Dolen Y, Jäger E, Beest MT, Zheng L, Figdor CG, Verdoes M.

Small. 2018 Apr;14(15):e1703539. doi: 10.1002/smll.201703539. Epub 2018 Mar 1.

PMID:
29493121
12.

Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment.

Gorris MAJ, Halilovic A, Rabold K, van Duffelen A, Wickramasinghe IN, Verweij D, Wortel IMN, Textor JC, de Vries IJM, Figdor CG.

J Immunol. 2018 Jan 1;200(1):347-354. doi: 10.4049/jimmunol.1701262. Epub 2017 Nov 15.

13.

Migrating into the Tumor: a Roadmap for T Cells.

van der Woude LL, Gorris MAJ, Halilovic A, Figdor CG, de Vries IJM.

Trends Cancer. 2017 Nov;3(11):797-808. doi: 10.1016/j.trecan.2017.09.006. Epub 2017 Nov 6. Review.

PMID:
29120755
14.

Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein.

Buschow SI, Ramazzotti M, Reinieren-Beeren IMJ, Heinzerling LM, Westdorp H, Stefanini I, Beltrame L, Hato SV, Ellebaek E, Gross S, Nguyen VA, Weinlich G, Ragoussis J, Baban D, Schuler-Thurner B, Svane IM, Romani N, Austyn JM, De Vries IJM, Schuler G, Cavalieri D, Figdor CG.

Oncotarget. 2017 Jun 27;8(40):67439-67456. doi: 10.18632/oncotarget.18698. eCollection 2017 Sep 15.

15.

Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity.

Hato SV, Figdor CG, Takahashi S, Pen AE, Halilovic A, Bol KF, Vasaturo A, Inoue Y, de Haas N, Verweij D, Van Herpen CML, Kaanders JH, van Krieken JHJM, Van Laarhoven HWM, Hooijer GKJ, Punt CJA, Asai A, de Vries IJM, Lesterhuis WJ.

Oncotarget. 2017 May 7;8(33):54434-54443. doi: 10.18632/oncotarget.17661. eCollection 2017 Aug 15.

16.

Synthetic immune niches for cancer immunotherapy.

Weiden J, Tel J, Figdor CG.

Nat Rev Immunol. 2018 Mar;18(3):212-219. doi: 10.1038/nri.2017.89. Epub 2017 Aug 30. Review.

PMID:
28853444
17.

Affinity-Based Purification of Polyisocyanopeptide Bioconjugates.

Hammink R, Eggermont LJ, Zisis T, Tel J, Figdor CG, Rowan AE, Blank KG.

Bioconjug Chem. 2017 Oct 18;28(10):2560-2568. doi: 10.1021/acs.bioconjchem.7b00398. Epub 2017 Sep 15.

PMID:
28846388
18.

N-glycan mediated adhesion strengthening during pathogen-receptor binding revealed by cell-cell force spectroscopy.

Te Riet J, Joosten B, Reinieren-Beeren I, Figdor CG, Cambi A.

Sci Rep. 2017 Jul 27;7(1):6713. doi: 10.1038/s41598-017-07220-w.

19.

A membrane-anchored aptamer sensor for probing IFNγ secretion by single cells.

Qiu L, Wimmers F, Weiden J, Heus HA, Tel J, Figdor CG.

Chem Commun (Camb). 2017 Jul 13;53(57):8066-8069. doi: 10.1039/c7cc03576d.

PMID:
28675396
20.

Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect.

Hammink R, Mandal S, Eggermont LJ, Nooteboom M, Willems PH, Tel J, Rowan AE, Figdor CG, Blank KG.

ACS Omega. 2017 Mar 31;2(3):937-945. doi: 10.1021/acsomega.6b00436. Epub 2017 Mar 16.

Supplemental Content

Loading ...
Support Center